TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27555187
Drug: Ultrasonography-guided transversus
Normalized name: Autologous CD34+ cells isolated from mobilised peripheral blood by positive selection, modified by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) mediated gene editing consisting of a guide RNA (gRNA)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Ultrasonography-guided transversus abdominis plane (TAP) block (0.5 mL/kg of 0.25% bupivacaine)
Study: 17440005
Drug: Activation of
Normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Activation of ICD therapies for atrial tachyarrhythmia (AT)/atrial fibrillation (AF)
Study: 8598422
Drug: Beta-carotene supplementation
Normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Beta-carotene supplementation (90 mg/day for 3 weeks)
Study: 11484954
Drug: Docetaxel +
Normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Docetaxel + Mitoxantrone + G-CSF
Study: 9112326
Drug: Chymopapain injection
Normalized name: Chymopapain
DrugBank: Chymopapain (DB06752)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Chymopapain injection
Study: 21518677
Drug: Sirolimus drug-eluting
Normalized name: Sirolimus
DrugBank: Sirolimus (DB00877)
Approvals — FDA: yes, EMA: yes, PMDA: yes
Description: Sirolimus drug-eluting stents (SES)
Study: 22512878
Drug: Intravenous glutamine
Normalized name: Glutamine
DrugBank: L-Glutamine (DB00130)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Intravenous glutamine
Study: 19100416
Drug: Valsartan 80
Normalized name: valsartan 80 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Valsartan 80 mg twice per day for 12 months
Study: 10731503
Drug: Iron and
Normalized name: beef,iron and wine
Approvals — FDA: no, EMA: no, PMDA: no
Description: Iron and folic acid supplements without zinc
Study: 7829693
Drug: Oral calcium
Normalized name: Coral Calcium
DrugBank: Sodium citrate (DB09154)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Oral calcium (25 mmol)
Study: 3050188
Drug: Ceftizoxime (CZX)
DrugBank: Ceftizoxime (DB01332)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Ceftizoxime (CZX) 20 mg/kg intravenous dose
Study: 19099634
Drug: Thalidomide +
Normalized name: Thalidomide
DrugBank: Thalidomide (DB01041)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: Thalidomide + MP chemotherapy (T-MP)
Study: 27233921
Drug: Calanus oil
Normalized name: CALANUS OIL
Approvals — FDA: no, EMA: no, PMDA: no
Description: Calanus oil (2 g daily for one year)
Study: 22510791
Drug: Vitamin D
Normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Vitamin D supplementation (1400 IU weekly from birth to 6 months)
Study: 19101220
Drug: Low-dose caldaret
Normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: Low-dose caldaret
Study: 2156887
Drug: Finasteride 50
Normalized name: Finasteride
DrugBank: Finasteride (DB01216)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Finasteride 50 mg
Study: 21218388
Drug: Oral antioxidant
Normalized name: antioxidant 119
Approvals — FDA: no, EMA: no, PMDA: no
Description: Oral antioxidant supplementation at nutritional doses
Study: 29325236
Drug: relamorelin 100
Normalized name: Relamorelin
DrugBank: Relamorelin (DB12678)
Approvals — FDA: no, EMA: no, PMDA: no
Description: relamorelin 100 μg subcutaneously daily
Study: 15226212
Drug: Postmenopausal hormone
Normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Postmenopausal hormone therapy (PHT)
Study: 10669272
Drug: Ropivacaine 0.75%
Normalized name: ROPivacaine 0.75% injectable solution
Approvals — FDA: no, EMA: no, PMDA: no
Description: Ropivacaine 0.75% plus 0.150 mg clonidine (Group II)
Study: 12755242
Drug: 3 mg
Normalized name: boron 3 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: 3 mg prostaglandin E2 vaginal tablets
Study: 30157896
Drug: 3 monthly
Normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
Approvals — FDA: yes, EMA: yes, PMDA: no
Description: 3 monthly ART supply at facilities
Study: 20618595
Drug: Walking exercise
Normalized name: ethanol
DrugBank: Ethanol (DB00898)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Walking exercise (daily from 18 weeks of gestation to the end of pregnancy)
Study: 21865944
Drug: Moderate glycemic
Normalized name: Glycerin
DrugBank: Glycerin (DB09462)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Moderate glycemic control (120‐180 mg/dL)
Study: 2195425
Drug: Silymarin (Legalon)
Normalized name: silymarin
Approvals — FDA: no, EMA: no, PMDA: no
Description: Silymarin (Legalon) therapy
Study: 31050956
Drug: Light therapy
Normalized name: kaolin light
Approvals — FDA: no, EMA: no, PMDA: no
Description: Light therapy (Bioptron)
Study: 26016586
Drug: Verbal oral
Normalized name: menthol
DrugBank: Menthol (DB14123)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Verbal oral health education
Study: 11152433
Drug: Amoxycillin 1
Normalized name: Amoxycillin
DrugBank: Amoxicillin (DB01060)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Amoxycillin 1 g bd
Study: 7577281
Drug: Target-controlled infusion
Normalized name: Diphtheria toxin-il-3 fusion protein targeting IL-3 receptor
DrugBank: Tagraxofusp (DB14731)
Approvals — FDA: yes, EMA: yes, PMDA: no
Description: Target-controlled infusion of propofol
Study: 2448428
Drug: Postoperative salvage
Normalized name: ethanol
DrugBank: Ethanol (DB00898)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Postoperative salvage chemotherapy with BCD and CPDD/ifosfamide (IFO)
Study: 2448428
Drug: Good responders
Normalized name: ethanol
DrugBank: Ethanol (DB00898)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Good responders receiving postoperative chemotherapy in control arm
Study: 18087084
Drug: 2 g
Normalized name: Molds 2 g
Approvals — FDA: no, EMA: no, PMDA: no
Description: 2 g single oral dose azithromycin
Study: 8087189
Drug: Nedocromil sodium
Normalized name: Nedocromil Sodium
DrugBank: Nedocromil (DB00716)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Nedocromil sodium (Ned) 4 mg
Study: 18313881
Drug: 5-FU-based treatment
Normalized name: 5-FU
DrugBank: Fluorouracil (DB00544)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: 5-FU-based treatment
Study: 20838060
Drug: Ibandronate 6
Normalized name: ibandronate
DrugBank: Ibandronate (DB00710)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Ibandronate 6 mg infused over 15 minutes every 3-4 weeks
Study: 30342638
Drug: Internal medicine
Normalized name: Medicaine Sting
Approvals — FDA: no, EMA: no, PMDA: no
Description: Internal medicine clerkships
Study: 15207890
Drug: Alendronate 70
Normalized name: ALENDRONATE 70MG TAB
Approvals — FDA: no, EMA: no, PMDA: no
Description: Alendronate 70 mg once weekly for 4 weeks followed by alendronate 10 mg once daily for 4 weeks
Study: 23241003
Drug: Sildenafil 25
Normalized name: sildenafil 25 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Sildenafil 25 mg twice a day for 2 weeks, then 50 mg 3 times a week for 10 weeks
Study: 24717789
Drug: GSK2190915 100
Approvals — FDA: no, EMA: no, PMDA: no
Description: GSK2190915 100 mg
Study: 10694619
Drug: Tranexamic acid
Normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Tranexamic acid (1 g in 100 mL of saline solution)
Study: 26016859
Drug: 250 mg
Normalized name: rutin 250 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: 250 mg magnesium oxide
Study: 18782316
Drug: Tacrolimus 0.1%
Normalized name: TACROLIMUS 0.1% OINT,TOP
DrugBank: Tacrolimus (DB00864)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Tacrolimus 0.1% ointment (MU)
Study: 14634544
Drug: Transdermal 17beta-estradiol
Normalized name: Estradiol-17beta
DrugBank: Estradiol (DB00783)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Transdermal 17beta-estradiol (E(2)) 50 microg
Study: 21029339
Drug: Angiotensin receptor
Normalized name: Angiotensin receptor
Approvals — FDA: no, EMA: no, PMDA: no
Description: Angiotensin receptor blockers
Study: 9179457
Drug: Vitamin B6
Normalized name: vitamin B6
DrugBank: Pyridoxine (DB00165)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Vitamin B6 (150 mg daily for 30 days)
Study: 18778916
Drug: Lamotrigine monotherapy
Normalized name: Lamotrigine
DrugBank: Lamotrigine (DB00555)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Lamotrigine monotherapy
Study: 27286961
Drug: Hyaluronic acid-carboxymethylcellulose
Normalized name: hyaluronic acid
DrugBank: Hyaluronic acid (non-animal stabilized) (DB19175)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Hyaluronic acid-carboxymethylcellulose treatment (n=30)
Study: 27707440
Drug: Vitamin D3
Normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Vitamin D3 supplementation (4,000 IU daily)
Study: 7918310
Drug: n-3 fatty
Normalized name: n-3 fatty acids
DrugBank: Omega-3 fatty acids (DB11133)
Approvals — FDA: no, EMA: no, PMDA: no
Description: n-3 fatty acid ethyl esters (3 g/d) administered to hypertriglyceridemic patients for 24 weeks
Study: 14519051
Drug: Beta-blockers and
Normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Beta-blockers and diuretics
Study: 20087154
Drug: Abacavir (ABC)
DrugBank: Abacavir (DB01048)
Approvals — FDA: yes, EMA: yes, PMDA: no
Description: Abacavir (ABC) + Tenofovir disoproxil fumarate (TDF) dual-therapy
Study: 12480610
Drug: Fluticasone propionate
Normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
Approvals — FDA: yes, EMA: yes, PMDA: yes
Description: Fluticasone propionate (FP) 100 microg twice a day
Study: 16373244
Drug: Red clover
Normalized name: Red clover
DrugBank: Trifolium pratense pollen (DB15530)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Red clover isoflavone supplement (80 mg/day)
Study: 27789350
Drug: DMPA 75
Normalized name: DMPA
DrugBank: Zytron (DB11768)
Approvals — FDA: no, EMA: no, PMDA: no
Description: DMPA 75 mg
Study: 27789350
Drug: DMPA 150
Normalized name: DMPA
DrugBank: Zytron (DB11768)
Approvals — FDA: no, EMA: no, PMDA: no
Description: DMPA 150 mg
Study: 19609105
Drug: Recombinant human
Normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
Approvals — FDA: yes, EMA: yes, PMDA: yes
Description: Recombinant human growth hormone (rhGH) at a low dose (3 microg/kg/day)
Study: 19609105
Drug: Recombinant human
Normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
Approvals — FDA: yes, EMA: yes, PMDA: yes
Description: Recombinant human growth hormone (rhGH) at a conventional dose (6 microg/kg/day)
Study: 31614532
Drug: Mung bean
Normalized name: MUNG BEAN
DrugBank: Mung bean (DB10830)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Mung bean protein supplementation (18 g/day)
Study: 22564837
Drug: Clarithromycin administered
Normalized name: Clarithromycin
DrugBank: Clarithromycin (DB01211)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Clarithromycin administered intravenously for 3 days
Study: 1483552
Drug: Ranitidine 150
Normalized name: ranitidine 150 MG
DrugBank: Ranitidine (DB00863)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Ranitidine 150 mg/day
Study: 25074865
Drug: Finasteride 1
Normalized name: finasteride 1 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Finasteride 1 mg tablet
Study: 11695069
Drug: Nimesulide 100
Normalized name: nimesulide 100 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Nimesulide 100 mg twice daily
Study: 21640044
Drug: FIN-RACo combination
Normalized name: Ongo-Fin
Approvals — FDA: no, EMA: no, PMDA: no
Description: FIN-RACo combination therapy (methotrexate, sulfasalazine, hydroxychloroquine, and prednisolone), n=69
Study: 20173082
Drug: Telcagepant single
Normalized name: Telcagepant
DrugBank: Telcagepant (DB12228)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Telcagepant single oral doses (up to 1200 mg)
Study: 25445851
Drug: Early voice
Normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Early voice therapy (within 4 weeks from injury)
Study: 9635630
Drug: Leuprolide acetate
Normalized name: Leuprolide Acetate
DrugBank: Leuprolide (DB00007)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Leuprolide acetate 7.5 mg
Study: 17509194
Drug: Letrozole 5
Normalized name: Letrozole
DrugBank: Letrozole (DB01006)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Letrozole 5 mg
Study: 15880077
Drug: Laparoscopic living-donor
Normalized name: Donor Human Stool
DrugBank: Fecal microbiota (DB17743)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Laparoscopic living-donor nephrectomy (L-LDN)
Study: 8888166
Drug: No specific
Normalized name: Oregano specific IgE
Approvals — FDA: no, EMA: no, PMDA: no
Description: No specific treatment (control)
Study: 1861510
Drug: Wei Yang
Normalized name: camphor
DrugBank: Camphor (DB01744)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Wei Yang An (easing peptic-ulcer capsule)
Study: 30629126
Drug: Higher protein
Normalized name: protein C
DrugBank: Protein C (DB11312)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Higher protein weight loss program (1.2-1.5 g/kg/d)
Study: 21960110
Drug: Hormone receptor-positive
Normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Hormone receptor-positive subgroup
Study: 6774845
Drug: 5700 rad
Normalized name: RAD-IFN
DrugBank: Nadofaragene firadenovec (DB17381)
Approvals — FDA: no, EMA: no, PMDA: no
Description: 5700 rad in 19 treatments, 24 days overall
Study: 8949759
Drug: Conformal photon
Normalized name: isopropyl alcohol
DrugBank: Isopropyl alcohol (DB02325)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Conformal photon irradiation (25 patients/78 Gy and 24 patients/83 Gy minimum dose)
Study: 27278921
Drug: Intravenous ferric
Normalized name: Ferric Oxide
DrugBank: Ferric oxide (DB11576)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Intravenous ferric carboxymaltose (FCM) 1000-1500 mg iron
Study: 27278921
Drug: Oral ferrous
Normalized name: ferrous fumarate Oral Capsule
Approvals — FDA: no, EMA: no, PMDA: no
Description: Oral ferrous sulfate (FS)
Study: 30652973
Drug: Isoquercetin 1000
Normalized name: Isoquercetin
DrugBank: Isoquercetin (DB12665)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Isoquercetin 1000 mg daily for 56 days
Study: 8587457
Drug: Pentaerithrityltetranitrate (PETN)
Normalized name: Pentaerythritol tetranitrate
DrugBank: Pentaerythritol tetranitrate (DB06154)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Pentaerithrityltetranitrate (PETN) treatment
Study: 16581549
Drug: Succimer treatment
Normalized name: Succimer
DrugBank: Succimer (DB00566)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Succimer treatment
Study: 25377359
Drug: High-dose ARA-C
Normalized name: cytarabine
DrugBank: Cytarabine (DB00987)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: High-dose ARA-C (HDAC)
Study: 25377359
Drug: Standard-dose ARA-C
Normalized name: cytarabine
DrugBank: Cytarabine (DB00987)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: Standard-dose ARA-C (SDAC)
Study: 31211178
Drug: naproxen 220
Normalized name: Today's Health Naproxen 220mg Tablet
Approvals — FDA: no, EMA: no, PMDA: no
Description: naproxen 220 mg b.i.d.
Study: 2033413
Drug: Alprazolam, 0.5
Normalized name: Alprazolam, 0.5 mg oral tablet
Approvals — FDA: no, EMA: no, PMDA: no
Description: Alprazolam, 0.5 mg three times a day
Study: 21486801
Drug: Control sites
Normalized name: PAD,BITE
Approvals — FDA: no, EMA: no, PMDA: no
Description: Control sites (no treatment)
Study: 15499953
Drug: 0.5 ml
Normalized name: ethanol 0.5 ML/ML
Approvals — FDA: no, EMA: no, PMDA: no
Description: 0.5 ml 30% glucose in spray form
Study: 2971506
Drug: Oral contraceptives
Normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Oral contraceptives
Study: 11387588
Drug: Enriched food
Normalized name: ALLERGENIC EXTRACT, FOOD, WHEAT
DrugBank: Wheat (DB10579)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Enriched food regimen (daily consumption of foods enriched with vitamins and minerals)
Study: 21123220
Drug: ICD therapy
Normalized name: Monistat Simple Therapy
Approvals — FDA: no, EMA: no, PMDA: no
Description: ICD therapy implanted later than 11 months after MI
Study: 18598093
Drug: Sildenafil 25
Normalized name: sildenafil 25 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Sildenafil 25 mg with DRV/r 400/100 mg
Study: 18293890
Drug: Early intracoronary
Normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Early intracoronary injection of CD133+ cells
Study: 20569451
Drug: Bazedoxifene 20
Normalized name: bazedoxifene 20 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Bazedoxifene 20 mg and 40 mg
Study: 2264362
Drug: Immunized groups
Normalized name: Streptococcus viridans group
Approvals — FDA: no, EMA: no, PMDA: no
Description: Immunized groups (both parenteral and oral)
Study: 6469442
Drug: Ginkgo biloba
Normalized name: Ginkgo Biloba
DrugBank: Ginkgo biloba (DB01381)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Ginkgo biloba extract 600 mg
Study: 3324563
Drug: Clenbuterol tablets
Normalized name: clenbuterol
DrugBank: Clenbuterol (DB01407)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Clenbuterol tablets (40 micrograms twice daily, later 20 micrograms twice daily)
Study: 29135651
Drug: Tenofovir film
Normalized name: Tenofovir
DrugBank: Tenofovir (DB14126)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: Tenofovir film (40 mg)
Study: 10629347
Drug: Glycine 1.0
Normalized name: LEUCINE 730 mg in 100 mL / PHENYLALANINE 560 mg in 100 mL / LYSINE HYDROCHLORIDE 580 mg in 100 mL / METHIONINE 400 mg in 100 mL / ISOLEUCINE 600 mg in 100 mL / VALINE 580 mg in 100 mL / HISTIDINE 480 mg in 100 mL / THREONINE 420 mg in 100 mL / TRYPTOPHAN 180 mg in 100 mL / ALANINE 2.07 g in 100 mL / GLYCINE 1.03 g in 100 mL / ARGININE 1.15 g in 100 mL / PROLINE 680 mg in 100 mL / TYROSINE 40 mg in 100 mL / SERINE 500 mg in 100 mL INTRAVENOUS INJECTION [Travasol]
Approvals — FDA: no, EMA: no, PMDA: no
Description: Glycine 1.0 g/day
Study: 23980239
Drug: Placebo mouth-rinse
Normalized name: phenol
DrugBank: Phenol (DB03255)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Placebo mouth-rinse (25 ml for 10 s, administered eight times)
Study: 17011248
Drug: Glibenclamide 3.5
Normalized name: Glibenclamide 3.5 mg oral tablet
Approvals — FDA: no, EMA: no, PMDA: no
Description: Glibenclamide 3.5 mg per dose
Study: 17295799
Drug: Sublingual immunotherapy
Normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Sublingual immunotherapy (SLIT) with tablets of HDM extract (n = 55)
Study: 29696666
Drug: Low-dose NS-0200
Normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: Low-dose NS-0200 (1.1 g leucine/0.5 g metformin/0.5 mg sildenafil)
Study: 21808751
Drug: Olanzapine SOT
Normalized name: Olanzapine
DrugBank: Olanzapine (DB00334)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Olanzapine SOT (10 to 20 mg, once daily)
Study: 25247897
Drug: Bupivacaine 0.25%
Normalized name: BUPIVACAINE 0.25%/NS INJ 400ML
Approvals — FDA: no, EMA: no, PMDA: no
Description: Bupivacaine 0.25% with dexmedetomidine 1 μg/kg (Group I - BD)
Study: 11119080
Drug: Combination of
Normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
Approvals — FDA: no, EMA: no, PMDA: no
Description: Combination of IRV and INO
Study: 20727177
Drug: Subgrouping for
Normalized name: RSV subgroup A stabilized prefusion F protein
DrugBank: Recombinant stabilized RSV A prefusion F antigen (DB18713)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Subgrouping for targeted treatment system
Study: 16116132
Drug: Botulinum toxin
Normalized name: Botulinum toxin
Approvals — FDA: no, EMA: no, PMDA: no
Description: Botulinum toxin A (BTX‐A) injections
Study: 11969277
Drug: Unfractionated heparin
Normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Unfractionated heparin (5000 U intravenous bolus, then 30,000 U 24 h(‐1), adjusted to an activated partial thromboplastin time 2‐2.5x normal)
Study: 10817084
Drug: cytomegalovirus immunoglobulin
Normalized name: cytomegalovirus immunoglobulin
DrugBank: Human cytomegalovirus immune globulin (DB13886)
Approvals — FDA: no, EMA: no, PMDA: no
Description: cytomegalovirus immunoglobulin G levels
Study: 29911802
Drug: Ephedrine nasal
Normalized name: ePHEDrine nasal
Approvals — FDA: no, EMA: no, PMDA: no
Description: Ephedrine nasal spray
Study: 3710634
Drug: Sustained release
Normalized name: Sustained Release Buccal Tablet
Approvals — FDA: no, EMA: no, PMDA: no
Description: Sustained release product E (1.0 g)
Study: 29141255
Drug: Escitalopram (ESC)
DrugBank: Escitalopram (DB01175)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Escitalopram (ESC) 10-30 mg (mean dose 15.2, SD±9.2)
Study: 10520732
Drug: 50 mg
Normalized name: talc 50 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: 50 mg amisulpride once daily for 4 days
Study: 27834418
Drug: Calcium (500
Normalized name: calcium gluconate 45 mg calcium (500 mg) ORAL TABLET
Approvals — FDA: no, EMA: no, PMDA: no
Description: Calcium (500 mg) and vitamin D (250 IU) supplementation twice a day for 6 months
Study: 22286551
Drug: Dexamethasone treatment
Normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: Dexamethasone treatment
Study: 26252749
Drug: Azithromycin 500
Normalized name: azithromycin 500 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Azithromycin 500 mg
Study: 9068739
Drug: benzoyl peroxide
Normalized name: Benzoyl Peroxide
DrugBank: Benzoyl peroxide (DB09096)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: benzoyl peroxide 5%/erythromycin 3% gel
Study: 9466049
Drug: 13-cis-retinoic acid
Normalized name: 13-cis-retinoic acid
DrugBank: Isotretinoin (DB00982)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: 13-cis-retinoic acid (1 mg/kg/day)
Study: 15643099
Drug: 10 mg
Normalized name: biotin 10 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: 10 mg oxazepam
Study: 11865786
Drug: EMLA anesthetic
Normalized name: Emla Anesthetic Disc
Approvals — FDA: no, EMA: no, PMDA: no
Description: EMLA anesthetic cream applied for 30 minutes
Study: 25840429
Drug: Sublingual misoprostol
Normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Sublingual misoprostol (400 mcg) 1 hour prior to surgery
Study: 25840429
Drug: Sublingual misoprostol
Normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Sublingual misoprostol (400 mcg) 3 hours prior to surgery
Study: 3315606
Drug: Intravenous anisoylated
Normalized name: Anisoylated plasminogen streptokinase activator complex
DrugBank: Anistreplase (DB00029)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Intravenous anisoylated plasminogen streptokinase activator complex (APSAC)
Study: 9476458
Drug: Benzathine penicillin
Normalized name: Benzathine penicillin G
Approvals — FDA: no, EMA: no, PMDA: no
Description: Benzathine penicillin (single dose)
Study: 28245726
Drug: Tadalafil 5
Normalized name: tadalafil 5 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Tadalafil 5 mg orally each night for 28 days
Study: 23354164
Drug: US-guided in-plain
Normalized name: CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Approvals — FDA: no, EMA: no, PMDA: no
Description: US-guided in-plain injection